How Companies Can Approach Wider Availability of COVID-19 Vaccines in the Coming Months

After a very difficult 2020, rapid vaccine development has sparked optimism among the public and in the business community. But there’s a long road ahead while infections remain high. During this transition period—when vaccines are becoming more widely available, but before the country achieves herd immunity— businesses should consider and anticipate a few things, including that certain individuals may not comply with COVID policies.